Related Experiment Videos
Learning effect and measurement variability in frequency-doubling technology perimetry in chronic open-angle glaucoma
Hiroshi Matsuo1, Goji Tomita, Yasuyuki Suzuki
1Department of Opthalmology, The University of Tokyo School of Medicine, Tokyo, Japan. hmatsuo-tky@umin.ac.jp
Journal of Glaucoma
|December 17, 2002
Summary
Glaucoma patients show learning effects with frequency-doubling technology perimetry. Repeat testing is recommended after initial screening to ensure reliable baseline measurements for glaucoma monitoring.
Area of Science:
- Ophthalmology
- Visual Science
Background:
- Glaucoma diagnosis and monitoring rely on visual field testing.
- Frequency-doubling technology (FDT) perimetry is a visual field test.
- Understanding learning effects and test-retest variability is crucial for accurate glaucoma management.
Purpose of the Study:
- To investigate learning effects and measurement variability of FDT perimetry.
- To assess the impact of prior automated static perimetry experience on FDT results.
- To determine optimal testing protocols for reliable FDT perimetry in glaucoma patients.
Main Methods:
- Prospective study of 44 patients with chronic open-angle glaucoma.
- Patients had prior experience with Humphrey automated static perimetry.
- FDT perimetry (N-30 full-threshold program) was administered three times at 1-3 month intervals after an initial screening (C-20-1 program).
Main Results:
- Significant improvement in mean deviation (MD) between the first and second FDT sessions (0.6 dB right eye, 0.8 dB left eye).
- Improved sensitivity in specific test points observed at the second session, but not sustained at the third.
- No significant differences in FDT results between the second and third sessions.
- Test-retest variability (standard deviation of MD) ranged from 3.8 to 4.0 dB.
Conclusions:
- Baseline FDT perimetry measurements in glaucoma patients demonstrate learning effects.
- Repeat testing is necessary to establish stable baseline values.
- Recommend at least two repeat N-30 full-threshold tests after initial C-20-1 screening for reliable perimetric follow-up.